AstraZeneca Pharma India informs about outcome of board meeting

11 Nov 2019 Evaluate

AstraZeneca Pharma India has informed that at the Board meeting of the Company held on Monday, November 11, 2019, the Board of Directors considered and approved the Unaudited Financial Results of the Company for the quarter ended September 30, 2019. The said Unaudited Financial Results together with the Limited Review report of the Statutory Auditors dated November 11, 2019 are enclosed herewith. 

The above information is a part of company’s filings submitted to BSE.

Astrazeneca Pharma I Share Price

9211.50 22.60 (0.25%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×